Guided Therapeutics Inc (GTHP) — 10-Q Filings
All 10-Q filings from Guided Therapeutics Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
GTHP's Losses Widen Amid Cash Burn, Despite Revenue Jump
— Nov 13, 2025 Risk: high
GUIDED THERAPEUTICS INC (GTHP) reported a net loss of $1.978 million for the nine months ended September 30, 2025, an increase from a net loss of $1.765 million -
GUIDED THERAPEUTICS' Losses Widen Amid Soaring Expenses
— Aug 14, 2025 Risk: high
GUIDED THERAPEUTICS INC reported a net loss of $1.236 million for the six months ended June 30, 2025, an increase from a net loss of $1.111 million in the prior -
Guided Therapeutics Files Q1 2025 10-Q, Evaluates Tax Disclosures
— May 15, 2025 Risk: medium
Guided Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, previously known as Spectrx Inc., is based in Peachtree Corners, GA. -
Guided Therapeutics Reports Q3 2024 Results
— Nov 14, 2024 Risk: medium
Guided Therapeutics Inc. reported its Q3 2024 results, with total assets valued at $500 million and total liabilities at $60.46 million as of September 30, 2024 -
Guided Therapeutics Reports Q2 2024 Results, Discloses Agreements
— Aug 14, 2024 Risk: medium
Guided Therapeutics Inc. reported its Q2 2024 results, showing total revenue of $54.1 million and a net loss of $0.001 million. The company also disclosed a Fin -
Guided Therapeutics Inc. Files 10-Q for Q1 2024
— May 14, 2024 Risk: medium
GUIDED THERAPEUTICS INC (GTHP) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Guided Therapeutics Inc. reported revenue of $818,000 for Q1 2024.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX